SEC INSIDER TRANSACTIONS

BIO-TECHNE Corp (TECH) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

TECH · BIO-TECHNE Corp

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Stale snapshot · Covered: filings 2026-10-15 to 2026-11-13 · 14 filings · fetched 2026-11-13T20:19:21Z

View six-calendar-month insider history →

Recent reported activity

0purchase rows on this page

0sale rows on this page

44matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-11-01Filed 2026-11-03	Hippel JamesOfficer · CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. F3 Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. F4 Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F5 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F8 4,011 restricted stock units vest on 8/15/2027. F9 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. F10 4,903 restricted stock units vest on 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. F11 7,479 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 7,480 restricted stock units vest on 8/17/2029. F12 36,459 restricted stock units vest on 8/17/2029. References: F5, F9	M Exercise / conversionRestricted Stock Units · Derivative	11,545D	0	Direct	Form 4 ↗0000914190-26-000174
2026-11-01Filed 2026-11-03	Hippel JamesOfficer · CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. F3 Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. F4 Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F5 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F8 4,011 restricted stock units vest on 8/15/2027. F9 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. F10 4,903 restricted stock units vest on 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. F11 7,479 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 7,480 restricted stock units vest on 8/17/2029. F12 36,459 restricted stock units vest on 8/17/2029. References:	F WithholdingCommon Stock · Non-derivative	5,096D	72.66	Direct	Form 4 ↗0000914190-26-000174
2026-11-01Filed 2026-11-03	Hippel JamesOfficer · CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. F3 Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. F4 Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F5 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F8 4,011 restricted stock units vest on 8/15/2027. F9 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. F10 4,903 restricted stock units vest on 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. F11 7,479 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 7,480 restricted stock units vest on 8/17/2029. F12 36,459 restricted stock units vest on 8/17/2029. References:	M Exercise / conversionCommon Stock · Non-derivative	11,545A	0	Direct	Form 4 ↗0000914190-26-000174
2026-11-01Filed 2026-11-03	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F3 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F4 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F5 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. F6 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F7 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F8 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F9 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F10 8,544 restricted stock units vest on 8/15/2027. F11 11,785 restricted stock units vest on 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F12 19,197 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 19,196 restricted stock units vest on 8/17/2029. F13 93,582 restricted stock units vest on 8/17/2029. References:	F WithholdingCommon Stock · Non-derivative	2,385D	72.66	Direct	Form 4 ↗0000914190-26-000175
2026-10-29Filed 2026-11-02	BAUMGARTNER ROBERT VDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	A Award / grantCommon Stock · Non-derivative	2,750A	0	Direct	Form 4 ↗0000914190-26-000155
2026-10-29Filed 2026-11-02	Bushman Julie LDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	A Award / grantCommon Stock · Non-derivative	2,750A	0	Direct	Form 4 ↗0000914190-26-000156
2026-10-29Filed 2026-11-02	HIGGINS JOHN LDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	A Award / grantCommon Stock · Non-derivative	2,750A	0	Direct	Form 4 ↗0000914190-26-000157
2026-10-29Filed 2026-11-02	KEEGAN JOSEPH DDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	A Award / grantCommon Stock · Non-derivative	2,750A	0	Direct	Form 4 ↗0000914190-26-000158
2026-10-29Filed 2026-11-02	Herr Amy E.Director Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully vested. F2 Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027. F3 Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F4 Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029. F5 Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028. F6 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F7 160 restricted stock units vest on 8/15/2027. F8 38 restricted stock units vest on 2/3/2027, and 39 restricted stock units vest on 2/3/2028. F9 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028. F10 460 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 461 restricted stock units vest on 8/17/2029. References:	A Award / grantCommon Stock · Non-derivative	2,750A	0	Direct	Form 4 ↗0000914190-26-000159
2026-10-29Filed 2026-11-02	Klimovsky Judith V.Director Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	A Award / grantCommon Stock · Non-derivative	2,750A	0	Direct	Form 4 ↗0000914190-26-000160
2026-10-29Filed 2026-11-02	Seth AlpnaDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	A Award / grantCommon Stock · Non-derivative	2,750A	0	Direct	Form 4 ↗0000914190-26-000161
2026-10-29Filed 2026-11-02	Vessey RupertDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	A Award / grantCommon Stock · Non-derivative	2,750A	0	Direct	Form 4 ↗0000914190-26-000162
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F6	M Exercise / conversionRestricted Stock Units · Derivative	2,332D	0	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F5	M Exercise / conversionRestricted Stock Units · Derivative	1,669D	0	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F4	M Exercise / conversionRestricted Stock Units · Derivative	49D	0	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F3	D Other reported codePerformance Restricted Stock Units · Derivative	4,432D	0	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F3	M Exercise / conversionPerformance Restricted Stock Units · Derivative	370D	0	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F1	D Other reported codePerformance Stock Option (Right to Buy) · Derivative	11,929D	0	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	1,366D	72.4	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Bohnen ShaneOfficer · SVP - General Counsel Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited. F4 49 restricted stock units vest on 8/15/2026. F5 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F6 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	4,420A	0	Direct	Form 4/A ↗0000914190-26-000167
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F3, F7	M Exercise / conversionRestricted Stock Units · Derivative	11,785D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F3, F6	M Exercise / conversionRestricted Stock Units · Derivative	8,543D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F3, F5	D Other reported codePerformance Restricted Stock Units · Derivative	8,698D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F3, F5	M Exercise / conversionPerformance Restricted Stock Units · Derivative	725D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F3, F4	D Other reported codePerformance Restricted Stock Units · Derivative	8,190D	0	Direct	Form 4/A ↗0000914190-26-000169

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.